Review





Similar Products

99
Thermo Fisher sh2 binding buffer
Overview of concerted experimental and computational strategy for generating <t>SH2‐peptide</t> binding free energy models. (a) Design of peptide‐display libraries. (b) Schematic showing how a randomized bacterial display library underwent repeated bead‐based affinity selection for SH2 binding. In each selection round, the library was sequenced before and after selection. (c) Overview of the regression framework used to learn energetic binding models from the sequencing data. For each possible binding site, the energy received independent additive contributions from the residues flanking the phosphorylated tyrosine, thus controlling for the binding‐site context wherein the residues reside. These energy contributions were estimated using maximum likelihood estimation, where the likelihood of the observed sequence counts was evaluated by first computing the total affinity for each observed sequence (controlling for multiple possible binding offsets and non‐specific binding) and then computing the binomial likelihood for each round, assuming linear section. (d) Sequence logo displaying the inferred energy contributions as letters whose height reflects the magnitude of the contributions, relative to the mean for each position.
Sh2 Binding Buffer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sh2/Tween+20/pmc12521615-205-30-79
Average 99 stars, based on 1 article reviews
sh2 binding buffer - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

94
Twist Bioscience bmx h sh2 sequence
<t>SH2-domain</t> substitutions increase fitness in BTK. Fitness scores for the 188 SH2-domain chimeras corresponding to Tec kinases or ancestral SH2 domains are shown. SH2 domains are ordered by their sequence relationships. The fitness bars, measured using the Jurkat assay, are colored by the human Tec kinase to which they are most closely related, requiring at least 75% sequence identity to display that color (sequences without 75% sequence identity to a human Tec kinase are colored purple). Error bars represent SEM and points are the individual replicate values. Sequence numbering corresponds to SI Appendix , Table S1 .
Bmx H Sh2 Sequence, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sh2/SynBio+Custom+Sequence/pmc12541323-177-1-7
Average 94 stars, based on 1 article reviews
bmx h sh2 sequence - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

86
Eurofins sh2 domain competition binding assays
Chemical structures of the 9 synthetic <t>SH2</t> domain ligands tested in SH2 scan . Compounds tested for binding selectivity in this study are shown in the above.
Sh2 Domain Competition Binding Assays, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sh2/assays+binding+radioligand/pmc12951562-140-15-11
Average 86 stars, based on 1 article reviews
sh2 domain competition binding assays - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

93
MedChemExpress stat3 phosphorylation inhibitor
Chemical structures of the 9 synthetic <t>SH2</t> domain ligands tested in SH2 scan . Compounds tested for binding selectivity in this study are shown in the above.
Stat3 Phosphorylation Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sh2/STAT3-SH2+domain+inhibitor+1/10__1002_slash_fft2__70139-86-15-20
Average 93 stars, based on 1 article reviews
stat3 phosphorylation inhibitor - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Proteintech sh2 domain
Chemical structures of the 9 synthetic <t>SH2</t> domain ligands tested in SH2 scan . Compounds tested for binding selectivity in this study are shown in the above.
Sh2 Domain, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sh2/SH2D1B+Antibody/pm41495798-110-60-76
Average 94 stars, based on 1 article reviews
sh2 domain - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
MedChemExpress stat3 inhibitor
Chemical structures of the 9 synthetic <t>SH2</t> domain ligands tested in SH2 scan . Compounds tested for binding selectivity in this study are shown in the above.
Stat3 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sh2/STAT3-SH2+domain+inhibitor+1/10__1002_slash_fft2__70139-86-12-20
Average 93 stars, based on 1 article reviews
stat3 inhibitor - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

86
Biacore convenient grb7 sh2 domains gst sh2
Chemical structures of the 9 synthetic <t>SH2</t> domain ligands tested in SH2 scan . Compounds tested for binding selectivity in this study are shown in the above.
Convenient Grb7 Sh2 Domains Gst Sh2, supplied by Biacore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sh2/convenient+domains+grb7+gst+sh2+sh2/pmc12468823-125-6-12
Average 86 stars, based on 1 article reviews
convenient grb7 sh2 domains gst sh2 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Overview of concerted experimental and computational strategy for generating SH2‐peptide binding free energy models. (a) Design of peptide‐display libraries. (b) Schematic showing how a randomized bacterial display library underwent repeated bead‐based affinity selection for SH2 binding. In each selection round, the library was sequenced before and after selection. (c) Overview of the regression framework used to learn energetic binding models from the sequencing data. For each possible binding site, the energy received independent additive contributions from the residues flanking the phosphorylated tyrosine, thus controlling for the binding‐site context wherein the residues reside. These energy contributions were estimated using maximum likelihood estimation, where the likelihood of the observed sequence counts was evaluated by first computing the total affinity for each observed sequence (controlling for multiple possible binding offsets and non‐specific binding) and then computing the binomial likelihood for each round, assuming linear section. (d) Sequence logo displaying the inferred energy contributions as letters whose height reflects the magnitude of the contributions, relative to the mean for each position.

Journal: Protein Science : A Publication of the Protein Society

Article Title: Accurate affinity models for SH2 domains from peptide binding assays and free‐energy regression

doi: 10.1002/pro.70317

Figure Lengend Snippet: Overview of concerted experimental and computational strategy for generating SH2‐peptide binding free energy models. (a) Design of peptide‐display libraries. (b) Schematic showing how a randomized bacterial display library underwent repeated bead‐based affinity selection for SH2 binding. In each selection round, the library was sequenced before and after selection. (c) Overview of the regression framework used to learn energetic binding models from the sequencing data. For each possible binding site, the energy received independent additive contributions from the residues flanking the phosphorylated tyrosine, thus controlling for the binding‐site context wherein the residues reside. These energy contributions were estimated using maximum likelihood estimation, where the likelihood of the observed sequence counts was evaluated by first computing the total affinity for each observed sequence (controlling for multiple possible binding offsets and non‐specific binding) and then computing the binomial likelihood for each round, assuming linear section. (d) Sequence logo displaying the inferred energy contributions as letters whose height reflects the magnitude of the contributions, relative to the mean for each position.

Article Snippet: To perform the single selection experiment using the phosphorylated peptide library against, 75 μL of streptavidin‐coated magnetic beads (DynabeadsTM FlowCompTM Flexi Kit, Thermo‐Fisher) were washed twice in 1 mL of SH2 binding buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 0.05% Tween 20, 1 mM TCEP) and incubated in a total of 150 μL SH2 binding buffer containing 20 μM biotinylated SH2 domain on a rotator at 4°C for 2–3 h in low protein‐binding microcentrifuge tubes (1.5 mL, Thermo ScientificTM).

Techniques: Binding Assay, Selection, Sequencing

Comparison of amino‐acid enrichment analysis and free‐energy regression. (a) Distribution of read counts (after down‐sampling to 500,000 reads) for sequences in the pTyrVar and X 5 YX 5 libraries, respectively, each before and after one round of affinity selection with the c‐Src SH2 domain. (b) Amino‐acid log‐enrichment due to affinity selection for c‐Src SH2, displayed as sequence logos, for the designed pTyrVar and random X 5 YX 5 library, respectively. (c) Direct comparison of log‐enrichment parameters between the two library designs. Red points indicate tyrosine, all other residues are gray. (d) Inferred free‐energy contributions (ΔΔ G /RT) at different positions within the c‐Src SH2 binding interface, displayed as sequence logos. Gray rectangles indicate position where the model was constrained to recognize (phospho)tyrosine. (e) Direct comparison of ΔΔ G/ RT parameters between the two library designs.

Journal: Protein Science : A Publication of the Protein Society

Article Title: Accurate affinity models for SH2 domains from peptide binding assays and free‐energy regression

doi: 10.1002/pro.70317

Figure Lengend Snippet: Comparison of amino‐acid enrichment analysis and free‐energy regression. (a) Distribution of read counts (after down‐sampling to 500,000 reads) for sequences in the pTyrVar and X 5 YX 5 libraries, respectively, each before and after one round of affinity selection with the c‐Src SH2 domain. (b) Amino‐acid log‐enrichment due to affinity selection for c‐Src SH2, displayed as sequence logos, for the designed pTyrVar and random X 5 YX 5 library, respectively. (c) Direct comparison of log‐enrichment parameters between the two library designs. Red points indicate tyrosine, all other residues are gray. (d) Inferred free‐energy contributions (ΔΔ G /RT) at different positions within the c‐Src SH2 binding interface, displayed as sequence logos. Gray rectangles indicate position where the model was constrained to recognize (phospho)tyrosine. (e) Direct comparison of ΔΔ G/ RT parameters between the two library designs.

Article Snippet: To perform the single selection experiment using the phosphorylated peptide library against, 75 μL of streptavidin‐coated magnetic beads (DynabeadsTM FlowCompTM Flexi Kit, Thermo‐Fisher) were washed twice in 1 mL of SH2 binding buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 0.05% Tween 20, 1 mM TCEP) and incubated in a total of 150 μL SH2 binding buffer containing 20 μM biotinylated SH2 domain on a rotator at 4°C for 2–3 h in low protein‐binding microcentrifuge tubes (1.5 mL, Thermo ScientificTM).

Techniques: Comparison, Sampling, Selection, Sequencing, Binding Assay

Multi‐round profiling of c‐Src SH2 using the naïve and pre‐enriched X 11 libraries. (a) Binding model learned using one selection round and starting with the naïve X 11 library. (b) Scatter plot comparing the model coefficients shown in panel (a) to the coefficients of the X 5 YX 5 model shown in Figure . Red points indicate tyrosine. (c), (d) Same as (a), (b) but showing a model that was trained on data from three selection rounds. (e), (f) Same as (a), (b) but showing a model that was trained on an experiment where the input library was pre‐selected using the 4G10 antibody, followed by two rounds of c‐Src SH2 binding selection. (g), (h) Same as (a), (b) but showing a model that was trained on data from the second and third selection rounds and that was not constrained to recognize tyrosine at the central position.

Journal: Protein Science : A Publication of the Protein Society

Article Title: Accurate affinity models for SH2 domains from peptide binding assays and free‐energy regression

doi: 10.1002/pro.70317

Figure Lengend Snippet: Multi‐round profiling of c‐Src SH2 using the naïve and pre‐enriched X 11 libraries. (a) Binding model learned using one selection round and starting with the naïve X 11 library. (b) Scatter plot comparing the model coefficients shown in panel (a) to the coefficients of the X 5 YX 5 model shown in Figure . Red points indicate tyrosine. (c), (d) Same as (a), (b) but showing a model that was trained on data from three selection rounds. (e), (f) Same as (a), (b) but showing a model that was trained on an experiment where the input library was pre‐selected using the 4G10 antibody, followed by two rounds of c‐Src SH2 binding selection. (g), (h) Same as (a), (b) but showing a model that was trained on data from the second and third selection rounds and that was not constrained to recognize tyrosine at the central position.

Article Snippet: To perform the single selection experiment using the phosphorylated peptide library against, 75 μL of streptavidin‐coated magnetic beads (DynabeadsTM FlowCompTM Flexi Kit, Thermo‐Fisher) were washed twice in 1 mL of SH2 binding buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 0.05% Tween 20, 1 mM TCEP) and incubated in a total of 150 μL SH2 binding buffer containing 20 μM biotinylated SH2 domain on a rotator at 4°C for 2–3 h in low protein‐binding microcentrifuge tubes (1.5 mL, Thermo ScientificTM).

Techniques: Binding Assay, Selection

Flanking specificity of the c‐Src, Grb2 and Fyn SH2 domains. (a) Energy logos for the c‐Src SH2, Fyn SH2 and Grb2 SH2 binding models. (b) Scatter plots comparing the predictions from the binding models in (a) with competitive fluorescence polarization measurements. Vertical bars indicate standard error. Dashed black lines (and accompanying model expressions and r 2 values) indicate linear regression fits to the log‐transformed K D ‐values. ( c ) Comparison of the c‐Src and Fyn binding models from (a) using an energy logo (top, showing the difference − ∆ ∆ ∆ G / RT between the model coefficients) and a scatter plot (bottom). (e), (d) AlphaFold 3 models of the c‐Src and Fyn SH2 domains (shown as surfaces in the central panels) bound to a high‐affinity phospho‐peptide (GHH‐pY‐EEIG, shown as purple sticks). Residues on the SH2 domains colored in beige are sites where c‐Src and Fyn diverge. A key divergent site (N201 in c‐Src and H199 in Fyn) is shown in teal. The zoom‐in panels highlight key residues in a cationic pocket on the SH2 domain that interacts with the ±1 residue on the peptide ligand.

Journal: Protein Science : A Publication of the Protein Society

Article Title: Accurate affinity models for SH2 domains from peptide binding assays and free‐energy regression

doi: 10.1002/pro.70317

Figure Lengend Snippet: Flanking specificity of the c‐Src, Grb2 and Fyn SH2 domains. (a) Energy logos for the c‐Src SH2, Fyn SH2 and Grb2 SH2 binding models. (b) Scatter plots comparing the predictions from the binding models in (a) with competitive fluorescence polarization measurements. Vertical bars indicate standard error. Dashed black lines (and accompanying model expressions and r 2 values) indicate linear regression fits to the log‐transformed K D ‐values. ( c ) Comparison of the c‐Src and Fyn binding models from (a) using an energy logo (top, showing the difference − ∆ ∆ ∆ G / RT between the model coefficients) and a scatter plot (bottom). (e), (d) AlphaFold 3 models of the c‐Src and Fyn SH2 domains (shown as surfaces in the central panels) bound to a high‐affinity phospho‐peptide (GHH‐pY‐EEIG, shown as purple sticks). Residues on the SH2 domains colored in beige are sites where c‐Src and Fyn diverge. A key divergent site (N201 in c‐Src and H199 in Fyn) is shown in teal. The zoom‐in panels highlight key residues in a cationic pocket on the SH2 domain that interacts with the ±1 residue on the peptide ligand.

Article Snippet: To perform the single selection experiment using the phosphorylated peptide library against, 75 μL of streptavidin‐coated magnetic beads (DynabeadsTM FlowCompTM Flexi Kit, Thermo‐Fisher) were washed twice in 1 mL of SH2 binding buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 0.05% Tween 20, 1 mM TCEP) and incubated in a total of 150 μL SH2 binding buffer containing 20 μM biotinylated SH2 domain on a rotator at 4°C for 2–3 h in low protein‐binding microcentrifuge tubes (1.5 mL, Thermo ScientificTM).

Techniques: Binding Assay, Fluorescence, Transformation Assay, Comparison, Residue

Flanking specificity for the Lyn, Yes and Blk SH2 domains. (a) Energy logos showing binding models for Lyn, Yes, and Blk. The models were trained on two‐round experiments using the X 5 YX 5 starting library. (b) Scatter plots comparing model predictions and validation measurements for the Lyn SH2 domain, shown as in Figure .

Journal: Protein Science : A Publication of the Protein Society

Article Title: Accurate affinity models for SH2 domains from peptide binding assays and free‐energy regression

doi: 10.1002/pro.70317

Figure Lengend Snippet: Flanking specificity for the Lyn, Yes and Blk SH2 domains. (a) Energy logos showing binding models for Lyn, Yes, and Blk. The models were trained on two‐round experiments using the X 5 YX 5 starting library. (b) Scatter plots comparing model predictions and validation measurements for the Lyn SH2 domain, shown as in Figure .

Article Snippet: To perform the single selection experiment using the phosphorylated peptide library against, 75 μL of streptavidin‐coated magnetic beads (DynabeadsTM FlowCompTM Flexi Kit, Thermo‐Fisher) were washed twice in 1 mL of SH2 binding buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 0.05% Tween 20, 1 mM TCEP) and incubated in a total of 150 μL SH2 binding buffer containing 20 μM biotinylated SH2 domain on a rotator at 4°C for 2–3 h in low protein‐binding microcentrifuge tubes (1.5 mL, Thermo ScientificTM).

Techniques: Binding Assay, Biomarker Discovery

Distribution of the predicted quantitative impact of missense variants in SH2 binding sites in the human proteome. Scatterplot of allelic effect of missense variation in SH2 binding sites documented in the PTMVar database of human phosphorylation site variants (Hornbeck et al., ), colored by the direction of the effect. The x ‐value corresponds to the greater of the predicted affinities of the two alleles, where relative affinity score is inversely proportional to the K D ; the y ‐value corresponds to the ratio of predicted affinities between the two alleles.

Journal: Protein Science : A Publication of the Protein Society

Article Title: Accurate affinity models for SH2 domains from peptide binding assays and free‐energy regression

doi: 10.1002/pro.70317

Figure Lengend Snippet: Distribution of the predicted quantitative impact of missense variants in SH2 binding sites in the human proteome. Scatterplot of allelic effect of missense variation in SH2 binding sites documented in the PTMVar database of human phosphorylation site variants (Hornbeck et al., ), colored by the direction of the effect. The x ‐value corresponds to the greater of the predicted affinities of the two alleles, where relative affinity score is inversely proportional to the K D ; the y ‐value corresponds to the ratio of predicted affinities between the two alleles.

Article Snippet: To perform the single selection experiment using the phosphorylated peptide library against, 75 μL of streptavidin‐coated magnetic beads (DynabeadsTM FlowCompTM Flexi Kit, Thermo‐Fisher) were washed twice in 1 mL of SH2 binding buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 0.05% Tween 20, 1 mM TCEP) and incubated in a total of 150 μL SH2 binding buffer containing 20 μM biotinylated SH2 domain on a rotator at 4°C for 2–3 h in low protein‐binding microcentrifuge tubes (1.5 mL, Thermo ScientificTM).

Techniques: Binding Assay, Phospho-proteomics

SH2-domain substitutions increase fitness in BTK. Fitness scores for the 188 SH2-domain chimeras corresponding to Tec kinases or ancestral SH2 domains are shown. SH2 domains are ordered by their sequence relationships. The fitness bars, measured using the Jurkat assay, are colored by the human Tec kinase to which they are most closely related, requiring at least 75% sequence identity to display that color (sequences without 75% sequence identity to a human Tec kinase are colored purple). Error bars represent SEM and points are the individual replicate values. Sequence numbering corresponds to SI Appendix , Table S1 .

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: BTK autoinhibition analyzed by high-throughput swaps of SH2 domains

doi: 10.1073/pnas.2502688122

Figure Lengend Snippet: SH2-domain substitutions increase fitness in BTK. Fitness scores for the 188 SH2-domain chimeras corresponding to Tec kinases or ancestral SH2 domains are shown. SH2 domains are ordered by their sequence relationships. The fitness bars, measured using the Jurkat assay, are colored by the human Tec kinase to which they are most closely related, requiring at least 75% sequence identity to display that color (sequences without 75% sequence identity to a human Tec kinase are colored purple). Error bars represent SEM and points are the individual replicate values. Sequence numbering corresponds to SI Appendix , Table S1 .

Article Snippet: The BMX-H SH2 sequence was purchased from Twist Bioscience as a gene fragment, which was then amplified using oligos #468 and #469 ( SI Appendix , Table S2 ).

Techniques: Sequencing

Screening αI kinase substitutions. The 118 αI kinase sequences are shown along with a multiple sequence alignment and fitness scores. The fitness scores are shown for the human BTK SH2 genetic background, the BMX-H SH2 genetic background, and the difference between these two backgrounds (BTK values subtracted from the BMX-H values). Error bars represent SEM and points represent the individual replicate values. For the difference values, error bars are determined using the SE propagation formula.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: BTK autoinhibition analyzed by high-throughput swaps of SH2 domains

doi: 10.1073/pnas.2502688122

Figure Lengend Snippet: Screening αI kinase substitutions. The 118 αI kinase sequences are shown along with a multiple sequence alignment and fitness scores. The fitness scores are shown for the human BTK SH2 genetic background, the BMX-H SH2 genetic background, and the difference between these two backgrounds (BTK values subtracted from the BMX-H values). Error bars represent SEM and points represent the individual replicate values. For the difference values, error bars are determined using the SE propagation formula.

Article Snippet: The BMX-H SH2 sequence was purchased from Twist Bioscience as a gene fragment, which was then amplified using oligos #468 and #469 ( SI Appendix , Table S2 ).

Techniques: Sequencing

Chemical structures of the 9 synthetic SH2 domain ligands tested in SH2 scan . Compounds tested for binding selectivity in this study are shown in the above.

Journal: Journal of Medicinal Chemistry

Article Title: SH2 scan : Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders

doi: 10.1021/acs.jmedchem.5c02613

Figure Lengend Snippet: Chemical structures of the 9 synthetic SH2 domain ligands tested in SH2 scan . Compounds tested for binding selectivity in this study are shown in the above.

Article Snippet: J.A.B. is a co-inventor on a pending patent application filed by Eurofins DiscoverX, LLC for SH2 domain competition binding assays.

Techniques: Binding Assay

SH2 scan assay principle for measuring compound dissociation constants. (a) An SH2 domain-containing protein construct (blue) fused to the NFκB DNA-binding domain (pink) is tagged with an exogenous double-stranded DNA (dsDNA) probe. This construct is incubated with a capture ligand (red) immobilized on magnetic beads (green). (b) In the presence of a competitor compound (yellow), less tagged protein is captured on the beads. The protein remaining on the beads is eluted using a high concentration of sodium phenyl phosphate, a generic competitor of phosphopeptide binding to SH2 domains. After elution, a lower qPCR signal is obtained at the end of the assay. In the presence of a noncompetitor compound ligand (brown), more tagged protein is captured on the beads and a high qPCR signal is observed. (c) Representative primary screening data for the STAT3 construct are shown. Compounds were tested at 10 μM and the hit cutoff for the compound screen was set at ≤ 35% of the average signal of the DMSO control wells for each construct (dashed line). Percent assay signal for each compound is expressed as the mean of at least two independent technical replicates from at least one independent experiment, ± standard deviation (exact numbers of replicates for each compound tested are shown in Supporting Table 3 ). (d) K D data for selected validated hits for the STAT3 construct are shown. Compounds were tested in dose–response ratio, and the data points were fit to the Hill equation (see Methods). Data are presented as mean percent assay signal from four independent technical replicates collected over two independent experiments ± standard error of the mean.

Journal: Journal of Medicinal Chemistry

Article Title: SH2 scan : Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders

doi: 10.1021/acs.jmedchem.5c02613

Figure Lengend Snippet: SH2 scan assay principle for measuring compound dissociation constants. (a) An SH2 domain-containing protein construct (blue) fused to the NFκB DNA-binding domain (pink) is tagged with an exogenous double-stranded DNA (dsDNA) probe. This construct is incubated with a capture ligand (red) immobilized on magnetic beads (green). (b) In the presence of a competitor compound (yellow), less tagged protein is captured on the beads. The protein remaining on the beads is eluted using a high concentration of sodium phenyl phosphate, a generic competitor of phosphopeptide binding to SH2 domains. After elution, a lower qPCR signal is obtained at the end of the assay. In the presence of a noncompetitor compound ligand (brown), more tagged protein is captured on the beads and a high qPCR signal is observed. (c) Representative primary screening data for the STAT3 construct are shown. Compounds were tested at 10 μM and the hit cutoff for the compound screen was set at ≤ 35% of the average signal of the DMSO control wells for each construct (dashed line). Percent assay signal for each compound is expressed as the mean of at least two independent technical replicates from at least one independent experiment, ± standard deviation (exact numbers of replicates for each compound tested are shown in Supporting Table 3 ). (d) K D data for selected validated hits for the STAT3 construct are shown. Compounds were tested in dose–response ratio, and the data points were fit to the Hill equation (see Methods). Data are presented as mean percent assay signal from four independent technical replicates collected over two independent experiments ± standard error of the mean.

Article Snippet: J.A.B. is a co-inventor on a pending patent application filed by Eurofins DiscoverX, LLC for SH2 domain competition binding assays.

Techniques: Construct, Binding Assay, Incubation, Magnetic Beads, Concentration Assay, Phospho-proteomics, Control, Standard Deviation

Primary screening across SH2 scan reveals unique binding selectivity signatures for synthetic ligands. Percent of DMSO control values were measured for each compound tested in this study and mapped as dots on a phylogenetic tree containing all 120 canonical human SH2 domains. Each dot plotted in a diagram represents a mean value collected from at least two independent technical replicates collected over at least one independent experiment, ± the standard deviation. Exact numbers of replicates for experiments are shown in Supporting Table 3 . The screening results for the two SH2 domains of SYK and ZAP70 are mapped as equivalently sized dots given that the SH2 domains for these targets are expressed in tandem constructs, and any competition observed cannot be unequivocally assigned to one or the other SH2 domain.

Journal: Journal of Medicinal Chemistry

Article Title: SH2 scan : Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders

doi: 10.1021/acs.jmedchem.5c02613

Figure Lengend Snippet: Primary screening across SH2 scan reveals unique binding selectivity signatures for synthetic ligands. Percent of DMSO control values were measured for each compound tested in this study and mapped as dots on a phylogenetic tree containing all 120 canonical human SH2 domains. Each dot plotted in a diagram represents a mean value collected from at least two independent technical replicates collected over at least one independent experiment, ± the standard deviation. Exact numbers of replicates for experiments are shown in Supporting Table 3 . The screening results for the two SH2 domains of SYK and ZAP70 are mapped as equivalently sized dots given that the SH2 domains for these targets are expressed in tandem constructs, and any competition observed cannot be unequivocally assigned to one or the other SH2 domain.

Article Snippet: J.A.B. is a co-inventor on a pending patent application filed by Eurofins DiscoverX, LLC for SH2 domain competition binding assays.

Techniques: Binding Assay, Control, Standard Deviation, Construct